drugset / Trial / NCT01210339

An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of Clopidogrel

NCT01210339

Phase 1 Completed 58 enrolled AstraZeneca
RandomizedCrossoverOpen-labelBasic science

Summary

The primary purpose of this study is to assess whether esomeprazole 20 mg/Acetyl Salicylic Acid (ASA) 81 mg affect the metabolism of clopidogrel.

Timeline

Start
2010-11
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 81 mg
Subject Clopidogrel Small molecule 75 mg
Subject Esomeprazole Small molecule 20 mg

Indications

No indication recorded.